SSKN Strata Skin Sciences

STRATA Skin Sciences to Present at Fall Harvest – Best Ideas from the Buy-Side on Wednesday, October 6th, 2021

STRATA Skin Sciences to Present at Fall Harvest – Best Ideas from the Buy-Side on Wednesday, October 6th, 2021

HORSHAM, Pa., Sept. 29, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that the Company has been invited to present at the Fall Harvest – Best Ideas from the Buy-Side conference. CEO, Robert J. Moccia will present at the conference.

STRATA Skin Sciences is scheduled to present on Wednesday, October 6th at 11:00 AM Eastern Time. Management will be available for one-on-one meetings to be held throughout the conference. Interested parties may access a live and archived webcast of the presentation on the investor section of the Company’s website at .

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email .

Investors can

About the MicroCap Rodeo Best Ideas Conference

The MicroCap Rodeo is back with its “Best Ideas” conference. This conference is a virtual conference that brings you the top 35 best ideas from the buy side. Qualified institutional investors recommended each of the 35 companies represented as one of their best ideas.

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® and now Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions.

The Company’s proprietary XTRAC and recently acquired Pharos excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone.

STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.

Investor Contacts:

Leigh Salvo
(415) 937-5404
 



EN
29/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Strata Skin Sciences

 PRESS RELEASE

STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and...

STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update HORSHAM, Penn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended June 30, 2025, and provides a corporate update. Second Quarter Highlights Historic expansion of CPT codes for reimbursement for inflammatory and auto-immune skin diseas...

 PRESS RELEASE

STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Co...

STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients Peer-reviewed publications continue to validate Excimer Laser efficacy in vitiligo and treatment STRATA updates status of non-Excimer laser false advertising litigation HORSHAM, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditio...

 PRESS RELEASE

STRATA Skin Sciences to Report Second Quarter 2025 Financial Results o...

STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update HORSHAM, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report second quarter 2025 financial results on Wednesday, August 13, 2025 after the market close. STRATA management will subsequently host a conference call at 4:30 p.m. ET on Wedne...

 PRESS RELEASE

STRATA Skin Sciences Announces Historic Expansion of CPT Codes for Rei...

STRATA Skin Sciences Announces Historic Expansion of CPT Codes for Reimbursement of 308nm Excimer Laser Treatments, Unlocking Access for Millions with Inflammatory and Auto-Immune Skin Diseases HORSHAM, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to advancing dermatologic care through innovation, announces that the American Medical Association (AMA) CPT Editorial Panel, in its May, 2025 summary of panel actions () has accepted revision to CPT codes 96920-96922, expanding reimbursement e...

 PRESS RELEASE

STRATA Skin Sciences Reports First Quarter 2025 Financial Results and ...

STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update HORSHAM, Pa., May 14, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended March 31, 2025, and provides a corporate update. First Quarter 2025 Financial Highlights Revenue in the first quarter of 2025 was $6.8 million, up 1% Global net recurring X...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch